TABLE I.
Clinical and demographic characteristics of gastric cancer patients assessed for Helicobacter pylori status
| Variable | H. pylori status [n (%)]
|
p Value | |
|---|---|---|---|
| Positive | Negative | ||
| Patients (n) | 188 | 73 | |
| Age | 0.034 | ||
| <61 Years | 97 (51.6) | 27 (37.0) | |
| ≥61 Years | 91 (48.4) | 46 (63.0) | |
| Sex | 0.117 | ||
| Women | 48 (25.5) | 12 (16.4) | |
| Men | 140 (74.5) | 61 (83.6) | |
| Tumour location | 0.880 | ||
| Distal (antrum or corpus) | 153 (81.4) | 60 (82.2) | |
| Proximal (cardia or fundus) | 35 (18.6) | 13 (17.8) | |
| uicc stage | 0.337 | ||
| i | 59 (31.4) | 20 (27.4) | |
| ii | 58 (30.9) | 19 (26.0) | |
| iii | 69 (36.7) | 31(42.5) | |
| iv | 2 (1.1) | 3 (4.1) | |
| Grade | 0.516 | ||
| Well differentiated | 6 (3.2) | 4 (5.5) | |
| Moderately differentiated | 64 (34.0) | 28 (38.4) | |
| Poorly differentiated | 118 (62.8) | 41 (56.2) | |
| Lauren classification | 0.231 | ||
| Intestinal | 116 (61.7) | 53 (72.6) | |
| Diffuse | 60 (31.9) | 16 (21.9) | |
| Mixed | 12 (6.4) | 4 (5.5) | |
| Adjuvant treatment | 0.241 | ||
| Yes | 135 (71.8) | 47 (64.4) | |
| No | 53 (28.2) | 26 (35.6) | |
| Status at last follow-up | 0.043 | ||
| Alive | 158 (84.0) | 53 (72.6) | |
| Dead | 29 (15.4) | 19 (26.0) | |
| Unknown | 1 (0.5) | 1 (1.4) | |
| Relapse | 0.042 | ||
| Yes | 31 (16.5) | 20 (27.4) | |
| No | 156 (83.0) | 52 (71.2) | |
| Unknown | 1 (0.5) | 1 (1.4) | |
uicc = Union Internationale Contre le Cancer.